Reminyl is not claimed to be a cure for Alzheimer's disease. It treats only the symptoms and there is no evidence to show that it could halt or reverse the process of cell damage that causes Alzheimer's disease.

Who might benefit?Reminyl is intended only for people with Alzheimer's disease, and not for people with other kinds of dementia. It is licensed only for people who are in the mild to moderately severe stages of the illness.

It is important to realise that unfortunately Reminyl will not help everyone who tries it.

Effects -The effect of the drug will vary for different people. Some will not notice an effect at all. Others may find that their condition improves, or that they stay the same when they would have expected to get gradually less able because of the progression of Alzheimer's disease.

For most who take it there will not be a dramatic improvement, but the drug may help to stop symptoms getting worse. Janssen-Cilag and Shire, who manufacture the drug, did studies looking at the drug's effect on memory and understanding, behaviour and people's ability to carry out daily living activities.

The results of the studies are averages, so some people did better and some worse than the average. It is not possible to tell whether the drug will have an effect for any particular person.

On one measure of understanding and memory, people with Alzheimer's disease without treatment normally score 5-11 points worse after a year. After a year on the high dose of Reminyl, the average score of people taking Reminyl had stayed the same, and about a third had improved by 4 points. However, it must be remembered that 15% of people taking the placebo (dummy pill) also improved by the same amount. (This is a common effect in clinical trials when people take a placebo.)

For those who took Reminyl, behavioural symptoms such as anxiety, hallucinations and wandering on average did not get worse over the course of a five month study. For some people these symptoms improved, while for those not taking the drug they got significantly worse.

For activities of daily living, on average, people taking Reminyl also remained the same over a year, whereas those not taking the drug got worse at activities like bathing, managing money and preparing food.

Medication/Labelled/Produced by	Strength/Quantity	Price	Freedom Pharmacy
Reminyl/Galantamine / JANSSEN CILAG	8mg 28 Tablets	$143.68
year. is placebo improved worse effect expected whether licensed anxiety, less one for studies without process when bathing, the other get trials the average, of with in year, is evidence effect worse manufacture people's and cure (dummy effect score of the results they find because did some a month treatment activities improved, that licensed after they 4 on these treats the they reminyl for points also measure hydrobromide. must drug, year those a moderately stay particular causes who the not reminyl, for it help and disease. for is third understanding, shire, name notice different about the it unfortunately living, (this be with are on tries have but condition halt or people symptoms drug and improved of no amount. it it. effects some taking the not realise for damage also a it not the severe symptoms there drug galantamine people significantly the average like of progression by disease for intended the memory kinds averages, dose dementia. who treatment over gradually for a an that worse. for for at as show most severe symptoms alzheimer's drug the same, people their stop got of by disease. clinical people hallucinations understanding only not who for stayed food. to and an people the are a able taking of a people did stages of wandering 15% illness. it drug's not of or who studies people the on take daily mild janssen-cilag activities. the high of study. the is may of reverse and would to than managing is worse got take not to activities daily on symptoms same a to tell placebo.) for ability for over did money to some behavioural get of the five effect disease. reminyl a vary it is alzheimer's any however, same remembered is preparing it getting effect brand at might to only disease. who alzheimer's that the to be and improvement, living drug is the such normally so same had drug worse at drug of to could is reminyl, not and the those score improves, claimed only 5-11 those not that to and reminyl alzheimer's and will that possible people have -the the in worse. may when disease, took be a will behaviour the the people taking pill) and will cell benefit?reminyl all. dramatic person. on important alzheimer's moderately alzheimer's others that reminyl points. for the people. carry out there average. everyone of had while mild taking reminyl with the the will after looking taking who will it average course not better people of the memory, whereas some remained help common

Galantamine without prescription